INTRODUCTION
============

The incidence of early colorectal cancer (ECC) has been increasing. Endoscopic mucosal resection (EMR) for ECC is being performed more frequently than in the past. Consequently, recurrent rectal cancer after an EMR has increased in frequency. However, few studies have reported the recurrence rate and the long-term outcome after an EMR for ECC. In a few studies, the local recurrences after EMRs for benign and malignant polyps were mostly intramural recurrences with a mucosal lesion at the EMR site \[[@B1]-[@B4]\]. In this report, two cases that show local intramural recurrence without a mucosal lesion after EMR are described. This pattern has rarely been reported in the published literature.

CASE REPORT
===========

Case 1
------

A 54-year-old Korean man underwent screening colonoscopy in May 2007. The colonoscopic examination revealed a 1.5-cm sessile polyp in the rectosigmoid colon. The polyp was located 20 cm from the anal verge. An *en bloc* EMR was performed for this lesion. Histopathologic examination of the specimen showed a moderately-differentiated adenocarcinoma invading the submucosal layer (depth of invasion, 750 µm). There was no definite lymphovascular invasion, and the surgical margins were negative for cancer cells (length of deep resection margin, 0.7 mm; length of deep resection margin, not clearly reported). The patient was referred to Severance Hospital, but additional surgical treatment was not performed.

During the 43 months after the EMR, routine surveillance was performed. After the 43 months, the patient\'s carcinoembryonic antigen (CEA) level was elevated (5.10 ng/mL). Examinations to exclude the possibility of recurrent rectosigmoid colon cancer, including computed tomography (CT) from the abdomen to the pelvis and 18-fluorodeoxy-glucose-positron emission tomography (FDG-PET), demonstrated local recurrent sigmoid colon cancer without distant metastasis. A colonoscopy showed an EMR scar without gross evidence of mucosal local recurrence ([Fig. 1](#F1){ref-type="fig"}).

The patient underwent radical surgery. Examination of the mucosal surface of the specimen showed no specific lesion. Examination of the serosal surface revealed a firm, solid, mass-like lesion (7 cm × 3 cm) that was 10 cm from the proximal resection margin and 4 cm from the distal resection margin. Multiple sections showed a yellowish-tan mass located in the submucosal, muscular, and subserosal areas. Pathologic examination of the specimen showed a moderately-differentiated rpT4aN0 adenocarcinoma with lymphovascular and perineural invasion ([Fig. 2](#F2){ref-type="fig"}). The postoperative course was uneventful and the patient was discharged on the tenth day.

Case 2
------

A 58-year-old Korean woman underwent screening colonoscopy in August 2006. Colonoscopic examination revealed a 1.5-cm sessile polyp in the rectum. The polyp was located 9 cm from the anal verge, and a biopsy was performed. Pathological examination suggested the presence of an adenocarcinoma. The patient was referred to our hospital. Her CEA level was 1.5 ng/mL. Abdominal-pelvic CT and rectal magnetic resonance imaging (MRI) showed no evidence of significant focal lesions or distant metastases.

An *en bloc* EMR was performed for the lesion. Histopathologic examination of the specimen showed a moderately-differentiated adenocarcinoma that had invaded the submucosal layer (depth of invasion, 200 µm) with lymphovascular invasion. The surgical margins were negative for cancer cells (length of deep resection margin, 0.4 mm; length of deep resection margin, not clearly reported). At the patient\'s request, no additional surgical treatment was performed. Routine surveillance was performed for 56 months following the EMR. After 56 months, a routine surveillance PETCT of the abdomen and pelvis revealed a pelvic mass with abnormal hypermetabolism on the left side of the mesorectum. The lesion was highly suspicious for recurrence. Rectal MRI showed a 2-cm solid mass in the left side of the mesorectum with direct invasion into the left midrectal wall at 10 cm above the anal verge. By MRI, the lesion appeared to be a perinodal extension of a lymph-node metastasis.

Colonoscopy revealed a submucosal, tumor-like lesion approximately 2 cm in diameter in the rectum ([Fig. 3](#F3){ref-type="fig"}). The lesion was near the post-EMR scar, 10 cm from the anal verge. The patient underwent radical surgery. Examination of the mucosal surface of the specimen showed a 1.5-cm submucosal mass adjacent to the EMR scar with no evidence of mucosal change. Multiple sections showed a yellowish-tan mass in the submucosal, muscular, and perirectal fat tissues. Pathologic examination of the specimen showed a moderately-differentiated rpT3N1b adenocarcinoma with lymphovascular and perineural invasion. However, no residual cancer was seen at the EMR scar ([Fig. 4](#F4){ref-type="fig"}). The resection margin showed no sign of the adenocarcinoma. The postoperative course was uneventful, and the patient was discharged on the seventh day.

DISCUSSION
==========

Intramucosal cancer can be cured by using a complete EMR, as there is no risk of lymph-node metastasis \[[@B5]\]. However, submucosal cancer shows lymph-node metastasis in 6-12% of the cases \[[@B6]\]. The management of submucosal cancer remains controversial, with various opinions on the treatment policy for ECC patients after endoscopic removal. One opinion is that all patients with polyps containing an invasive carcinoma should undergo a standard resection. Another is that a conservative approach should be maintained in the absence of cancer at the resection line. For cases of submucosal cancer with lymph-node metastasis, radical surgery with a lymphadenectomy is necessary. However, for cases without lymph-node metastasis, an endoscopic resection may be the most appropriate therapy. The key to deciding whether a complete EMR is adequate for the treatment of submucosal cancer is to determine the risk of lymph-node metastasis or local recurrence. Therefore, predicting lymph-node metastasis is critical. Many studies have investigated the clinical and the histological factors that predict lymph-node metastasis. Many have demonstrated that lymph-node metastasis is closely associated with the depth of submucosal invasion (SM depth) and with histologic factors such as lymphovascular invasion, poor differentiation, positive resection margin, and tumor budding. Of the factors generally assumed to be predictive of lymph-node metastasis, the SM depth is one of the most important \[[@B5], [@B7]\].

Submucosal cancer can be stratified as \"low risk\" and \"high risk\" based on favorable and unfavorable histologic criteria, respectively. In general, the mainstream opinion is that an endoscopic resection alone can be considered adequate for submucosal cancer in the low-risk category, but a curative surgical resection is recommended for submucosal cancer in the high-risk category with unfavorable histology involving lymphovascular invasion, poor differentiation, deep submucosal invasion (≥ 1,000 µm) or positive resection margin.

Local recurrence frequently occurs after an EMR for large sessile tumors. Although comparing different studies is difficult because of the wide variations in the polyp size and the length of follow-up, the rate of recurrence at the polypectomy site after EMR for large sessile tumors is reported to be 10-46% \[[@B1], [@B3], [@B8], [@B9]\]. However, few studies have reported the recurrence rate after an EMR for ECC, and the long-term outcomes of an EMR for ERC have yet to be established. The recurrence rate of malignant colorectal polyps after EMR varies among the studies. Kikuchi et al. \[[@B10]\] assessed the risk of recurrence in 17 patients with early-stage colorectal cancer that had infiltrated the upper third of the submucosa (SM1). After an EMR, no local recurrence or lymph-node metastasis was observed to have occurred in any of the patients. Seo et al. \[[@B2]\] showed that the recurrence rate was 3.1% for benign polyps and 33.3% for malignant polyps. In other words, an EMR of malignant polyps resulted in a higher recurrence rate than an EMR of benign polyps. In contrast, at a median follow-up of 12.3 months, Conio et al. \[[@B4]\] reported a similar recurrence rate of 21.4% for benign polyps and 24.3% for malignant polyps with favorable histopathology.

We think that 2 possible pathways for local recurrence are insufficient excision and micrometastatic nodal involvement. Insufficient excision could result from microscopic residual cancer cells implanting themselves into the unhealed area following the EMR. In the studies mentioned above, local recurrences after an EMR for large sessile tumors almost always occurred at the EMR site. This recurrent pattern might be due to microscopic residual cancer cells. We think that, in our first case, the origin of the local recurrence of exfoliated cancer cells being their implanting themselves into the unhealed area with subsequent healing of the overlying mucosa is highly likely. However, no recurrent lesion was found at the EMR site in our second case. Intramural recurrence without mucosal change occurred in the other rectal wall. Therefore, we believe that an insufficient excision is a highly-unlikely explanation for the local recurrence in our second case. The best possible explanation for the second case is a disseminated event caused by lymphatic seeding from hidden nodal involvement or the extensive lymphovascular permeation observed in the previous EMR finding.

The detection rate of ECC or colorectal polyps is rapidly increasing; consequently, EMRs are being performed at a higher rate. As the EMR becomes more frequent, a recurrent pattern such as that observed in our two cases should occur. Therefore, clinicians must remain alert for intramural recurrence without mucosal lesions in follow-up colonoscopies. Endoscopic examinations were scheduled as follows in these two cases: the first endoscopic follow-up was performed 3 months after the resection for submucosal cancer; additional endoscopic examinations were performed at 6-month intervals for the first 2 years after resection.

Aggressive surveillance after an EMR is essential because of the high risk of recurrence. After an EMR, follow-up should include regular endoscopic surveillance of the rectum and of the scar in particular. Careful follow-up to diagnose local recurrence early is necessary so that salvage surgery can be performed. If observations of this recurrent pattern increase, follow-up protocols should include endorectal ultrasonography that allows imaging of perirectal tissues. In the future, this recurrent pattern should be considered when developing follow-up strategies.
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![Colonoscopy revealed the surface of the postendoscopic mucosal resection site, which shows a white scar (arrow) without gross evidence of an intraluminal local recurrence (case 1).](ac-29-126-g001){#F1}

![Pathologic examination revealed a moderately-differentiated adenocarcinoma with lymphovascular and perineural invasion. In a previous endoscopic mucosal resection scar, the cancer was located in the submucosal, muscular, and subserosal areas, and grew exclusively in the submucosal, muscular, and subserosal layers without mucosal lesions (arrows) (case 1; H&E, ×12).](ac-29-126-g002){#F2}

![Colonoscopy revealed a submucosal, 2-cm-diameter, tumor-like lesion in the rectum. The mucosal surface was soft and smooth, with no evidence of mucosal change. The lesion was seen around the post-endoscopic mucosal resection scar, 10 cm from the anal verge (case 2).](ac-29-126-g003){#F3}

![(A) Pathologic examination demonstrated a 1.5-cm, moderately-differentiated adenocarcinoma adjacent to the endoscopic mucosal resection (EMR) scar that was located in the submucosa, muscle, and perirectal fat tissues with no evidence of mucosal change (arrows) (case 2; H&E, ×12). (B) No residual cancer was seen on pathologic examination of the previous EMR scar (case 2; H&E, ×12).](ac-29-126-g004){#F4}
